Michael G Fradley MD
Cardiac Electrophysiology
Medical Director, Penn Cardio-Oncology, Associate Professor of Clinical Medicine
Join to View Full Profile
3400 Civic Center Blvd -- PCAM3rd FloorPhiladelphia, PA 19104
Phone+1 215-662-7700
Fax+1 215-349-5533
Dr. Fradley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Clinical Cardiac Electrophysiology, 2011 - 2012- Mass General Brigham/Massachusetts General HospitalFellowship, Cardiovascular Disease, 2008 - 2011
Johns Hopkins UniversityResidency, Internal Medicine, 2005 - 2008- Johns Hopkins University School of MedicineClass of 2005
Certifications & Licensure
PA State Medical License 2020 - 2026
FL State Medical License 2013 - 2021
MA State Medical License 2008 - 2014
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Clinical Trials
- Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy Start of enrollment: 2014 Nov 01
- Long Term Arrhythmia Risk and Cardiovascular Events in Hematopoietic Stem Cell Transplant Start of enrollment: 2021 Apr 21
Publications & Presentations
PubMed
- 2 citationsImpact of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy.Stefano H Byer, Aravinthasamy Sivamurugan, Udhayvir S Grewal, Michael G Fradley, Paari Dominic
The American Journal of Cardiology. 2025-05-15 - Atrial fibrillation and ischemic stroke in cancer: the latest scientific evidence, current management, and future directions.Lakshya Seth, Nickolas Stabellini, Shawn Doss, Vraj Patel, Viraj Shah
Journal of Thrombosis and Thrombolysis. 2025-04-26 - A comparison of healthcare resource utilization and costs between patients with chronic lymphocytic leukemia treated with first-line ibrutinib or acalabrutinib using t...Kerry A Rogers, Benyam Muluneh, Zaina P Qureshi, Jinghua He, Alex Bokun
Journal of Comparative Effectiveness Research. 2025-04-22
Press Mentions
Lung Cancer Drug Osimertinib Tied to Cardiac Events, Even in Low-Risk PatientsDecember 12th, 2024- Heart Failure Risk Lingers Long After Chemotherapy, Regardless of DoseFebruary 3rd, 2023
- Cardio-Oncology Topics from AHA 2020August 17th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
